Skip links

AI low-dose CT, proven performance in multinational clinical trials

2022-09-20

AI low-dose CT, proven performance in multinational clinical trials

The artificial intelligence (AI) low-dose CT technology developed in Korea has proven its performance in the first multinational clinical trial.